P4HAS as modifiers of the IGFR pathway and methods of use

Details for Australian Patent Application No. 2005265214 (hide)

Owner Exelixis, Inc.

Inventors Francis-Lang, Helen; Shaw, Kenneth James; Friedman, Lori S.; Bjerke, Lynn Margaret; Parks, Annette L.; Heuer, Timothy S.

Agent Davies Collison Cave

Pub. Number AU-A-2005265214

PCT Pub. Number WO2006/009952

Priority 60/581,696 21.06.04 US

Filing date 20 June 2005

Wipo publication date 26 January 2006

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2006/009952 Priority application(s): WO2006/009952

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265221-Method and apparatus for evaluating animals' health and performance

2005265212-Aldos as modifiers of the IGF pathway and methods of use